Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 4:49 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 1,583 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetes Mellitus, Juvenile-Onset Clear all

Conditions: Type 1 Diabetes
Interventions: Diabetes Strengths Study; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 12 Years to 18 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetes Mellitus, Type 1
Interventions: LY3532226, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Type 1 Diabetes
Interventions: Resveratrol, Placebo; Drug · Other
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Type 1 Diabetes
Interventions: Intradermal injection, Subcutaneous injection; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes, Latent Autoimmune Diabetes in Adults, Pancreatitis
Interventions: Digital Exercise; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 30 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Type 1 Diabetes Mellitus
Interventions: AID System, Insulin Lispro; Device · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Type 1 Diabetes Mellitus
Interventions: Ultra-Rapid Lispro, Insulin Lispro; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 471 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 32
States / cities: Concord, California • Fresno, California • Greenbrae, California + 28 more

Conditions: Type 1 Diabetes
Interventions: Terbutaline, 20% basal insulin reduction, Control; Drug · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 10 Years to 17 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Diabetes Mellitus, Type 1
Interventions: Hybrid Closed Loop Insulin Pump System; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Santa Monica, California • Sylmar, California • Torrance, California

Conditions: Type 1 Diabetes
Interventions: Diabetes behavior change skills training, Physical activity promotion program; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 13 Years to 17 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Type 1 Diabetes
Interventions: Extended Wear Infusion Set, Standard Infusion Set; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Diabetes
Interventions: Extended Infusion Set; Device
Lead sponsor: Medtronic MiniMed, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 15
States / cities: Little Rock, Arkansas • Escondido, California • Palo Alto, California + 12 more

Conditions: Type 1 Diabetes
Interventions: Mini-glucagon, Remote monitoring, Carbohydrates; Drug · Device · Dietary Supplement
Lead sponsor: Stanford University; Other
Eligibility: 7 Years to 21 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Non-Alcoholic Fatty Liver Disease, Non Insulin Dependent Diabetes, ALT
Interventions: Betaine (trimethyglycine); Dietary Supplement
Lead sponsor: Southern California Institute for Research and Education; Other
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Type 1 Diabetes
Interventions: HIT-aided approach, Contracted conflict management system, HIT plus contracted conflict management; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Carmel, Indiana • Indianapolis, Indiana

Conditions: Type 1 Diabetes, Obesity
Interventions: Semaglutide, Placebo; Drug
Lead sponsor: Viral N. Shah; Other
Eligibility: 18 Years to 65 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Aurora, Colorado • West Des Moines, Iowa • Detroit, Michigan + 1 more

Conditions: Type 1 Diabetes Mellitus
Interventions: Humalog, Novolog, BC222 insulin lispro, Bionic Pancreas; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Virtual Clinic; Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Type 1 Diabetes
Interventions: FAMS-T1D, Digital resources for diabetes; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 24 Years
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Salt Lake City, Utah

Conditions: Diabetes Mellitus, Type 1
Interventions: Internet co-management module; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 39 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Not listed
Lead sponsor: VeraLight, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Hyattsville, Maryland

Conditions: Hypoglycemia; Iatrogenic
Interventions: Low Fructose, Saline, Somatostatin, Insulin, Glucagon, Dextrose solution, High Fructose; Drug
Lead sponsor: Jason Winnick; Other
Eligibility: 21 Years to 40 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diabetes, Diabetes Mellitus, Type 1
Interventions: insulin detemir, insulin glargine, insulin aspart; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 28
States / cities: Anaheim, California • Huntington Beach, California • Inglewood, California + 24 more

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: INGAP Peptide; Drug
Lead sponsor: GMP Endotherapeutics; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 4
States / cities: San Diego, California • Washington D.C., District of Columbia • Durham, North Carolina + 1 more